03-19829. Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Research Initiative To Build Capacity in Black and Hispanic ...  

  • Start Preamble

    In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Minority Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) Research Initiative to Build Capacity in Black and Hispanic Communities and Among Researchers Who Conduct HIV/AIDS Epidemiologic and Prevention Research in these Communities, Program Announcement Number 03097.

    Times and Dates: 8:30 a.m.-9 a.m., August 18, 2003 (Open). 9 a.m.-5 p.m., August 18, 2003 (Closed). 8:30 a.m.-5 p.m., August 19, 2003 (Closed).

    Place: The Westin Hotel at Perimeter, 7 Concourse Parkway, Atlanta, GA 30328, Telephone 770.395.3900.

    Status: Portions of the meeting will be closed to the public in accordance with provisions set forth in Section552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

    Matters to be Discussed: The meeting will include the review, discussion, and evaluation of applications received in response to Program Announcement Number 03097.

    Note:

    Due to program oversight, this Federal Register Notice is being published less than 15 days before the date of the meeting.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Beth Wolfe, Prevention Support Office, National Center for HIV, STD, and TB Prevention, CDC, 1600 Clifton Road, NE., MS-E07, Atlanta, GA 30333, Telephone 404.639.8531.

    The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

    Start Signature

    Dated: July 30, 2003.

    Alvin Hall,

    Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).

    End Signature End Further Info End Preamble

    [FR Doc. 03-19829 Filed 7-31-03; 11:41 am]

    BILLING CODE 4163-18-P

Document Information

Published:
08/04/2003
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
03-19829
Dates:
8:30 a.m.-9 a.m., August 18, 2003 (Open). 9 a.m.-5 p.m., August 18, 2003 (Closed). 8:30 a.m.-5 p.m., August 19, 2003 (Closed).
Pages:
45825-45825 (1 pages)
PDF File:
03-19829.pdf